STAAR Surgical (STAA) CFO Andrews acquired 34,742 shares
Insider transactions reported
Deborah J Andrews (Chief Financial Officer & EVP at STAAR Surgical Company, STAA) reported that they acquired 34,742 shares, and gave up 17,056 shares at an average $26.96 to cover taxes or an exercise price between Jun 25, 2026 and Jul 31, 2026. After these transactions the filing shows 36,339 shares held directly.
- Reporting person
- Andrews Deborah J
- Role
- Chief Financial Officer & EVP
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Exercise or conversion of a derivative (M) | Common Stock1 | +13,955 | - | - | 32,608 direct |
| Jun 25, 2026 | Shares withheld for taxes or exercise price (F) | Common Stock | -6,480 | $31.21 | $202K | 26,128 direct |
| Jul 31, 2026 | Exercise or conversion of a derivative (M) | Common Stock2 | +20,787 | - | - | 46,915 direct |
| Jul 31, 2026 | Shares withheld for taxes or exercise price (F) | Common Stock | -10,576 | $24.36 | $258K | 36,339 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 13,955 Common Stock1 | -13,955 | - | - | 27,912 direct |
| Jul 31, 2026 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 20,787 Common Stock2 | -20,787 | - | - | 0 direct |
Holdings before and after
- Common Stock: 18,653 to 36,339 direct
- Restricted Stock Units: 41,867 to 0 direct
Footnotes from the filing
- 1. Represents the vesting of restricted stock units ( RSUs ) granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis.
- 2. Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Andrews report in this STAA Form 4?
Deborah J Andrews (Chief Financial Officer & EVP at STAAR Surgical Company, STAA) reported that they acquired 34,742 shares, and gave up 17,056 shares at an average $26.96 to cover taxes or an exercise price between Jun 25, 2026 and Jul 31, 2026. After these transactions the filing shows 36,339 shares held directly.
How many STAA shares does Andrews hold after this filing?
The filing shows 36,339 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for STAA
Across the 19 sessions after earlier STAA headlines, the stock closed higher 10 times and lower 8 times, with a median move of 4.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | STAA | SPY |
|---|---|---|---|
| Aug 5, 2026 | STAAR Surgical Appoints Warren Foust as President and Chief Executive Officerand 1 other headline that session | -5.2% | -0.2% |
| Jul 28, 2026 | UBS initiated coverage on STAAR Surgical with a new price target | -1.3% | +0.2% |
| Jul 17, 2026 | STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026 | -8.8% | -1.0% |
| May 22, 2026 | STAAR Surgical Announces Participation in Upcoming Investor Conferences | -1.0% | +0.4% |
| May 14, 2026 | STAAR Surgical upgraded by Wedbush with a new price targetand 1 other headline that session | +8.9% | +0.8% |
| May 5, 2026 | STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026 | +0.6% | +0.8% |
Earlier insider filings at STAA
- Jun 23, 2026SEC Form 4 filed by Director Wang Christopher Min Fang
- Jun 22, 2026SEC Form 4 filed by Director Lebuhn Richard T.
- Jun 22, 2026SEC Form 4 filed by Director Bradsher Neal C
- Jun 22, 2026Director Butcher Arthur C converted options into 5,341 shares, increasing direct ownership by 127% to 9,549 units (SEC Form 4)
- Jun 22, 2026SEC Form 4 filed by Director Zhou Lilian Yansheng
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Ophthalmic Goods
Follow STAA and get a push notification the moment its next story breaks.